Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $27.0000 (2.27%) ($25.7900 - $27.3000) on Thu. Jan. 5, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.47% (three month average) | RSI | 54 | Latest Price | $27.0000(2.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.7% a day on average for past five trading days. | Weekly Trend | CAPR advances 4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWI(7%) PEJ(7%) SKYY(7%) XLF(7%) ARKK(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.235% in a week (0% probabilities). TLT(-6%) GLD(-6%) GDX(-6%) VIXM(-5%) SLV(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.235% (StdDev 4.47%) | Hourly BBV | 0 () | Intraday Trend | 3.1% | | | |
|
5 Day Moving Average | $26.96(0.15%) | 10 Day Moving Average | $26.19(3.09%) | 20 Day Moving Average | $26.08(3.53%) | To recent high | -22.9% | To recent low | 12.5% | Market Cap | $532m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |